Ngo et al., 2022 - Google Patents
Sensitive and quantitative point-of-care HIV viral load quantification from blood using a power-free plasma separation and portable magnetofluidic polymerase chain …Ngo et al., 2022
View PDF- Document ID
- 298674197542361488
- Author
- Ngo H
- Jin M
- Trick A
- Chen F
- Chen L
- Hsieh K
- Wang T
- Publication year
- Publication venue
- Analytical Chemistry
External Links
Snippet
Point-of-care (POC) HIV viral load (VL) tests are needed to enhance access to HIV VL testing in low-and middle-income countries (LMICs) and to enable HIV VL self-testing at home, which in turn have the potential to enhance the global management of the disease …
- 210000002381 Plasma 0 title abstract description 219
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Song et al. | Point-of-care testing detection methods for COVID-19 | |
Zhu et al. | The vision of point-of-care PCR tests for the COVID-19 pandemic and beyond | |
Vidic et al. | Point-of-need DNA testing for detection of foodborne pathogenic bacteria | |
Mauk et al. | Simple approaches to minimally-instrumented, microfluidic-based point-of-care nucleic acid amplification tests | |
Song et al. | Instrument-free point-of-care molecular detection of Zika virus | |
Liu et al. | Membrane-based, sedimentation-assisted plasma separator for point-of-care applications | |
Niemz et al. | Point-of-care nucleic acid testing for infectious diseases | |
Haleyur Giri Setty et al. | Point of care technologies for HIV | |
Ritzi-Lehnert | Development of chip-compatible sample preparation for diagnosis of infectious diseases | |
Hart et al. | Point‐of‐care oral‐based diagnostics | |
Zhao et al. | Multifunctional sample preparation kit and on-chip quantitative nucleic acid sequence-based amplification tests for microbial detection | |
US10589270B2 (en) | Digital fluid sample separation apparatus and methods for one-step quantitative sample analysis | |
Ngo et al. | Sensitive and quantitative point-of-care HIV viral load quantification from blood using a power-free plasma separation and portable magnetofluidic polymerase chain reaction instrument | |
Cunha et al. | Sample preparation for lab-on-a-chip systems in molecular diagnosis: a review | |
Wu et al. | Rotary valve-assisted fluidic system coupling with CRISPR/Cas12a for fully integrated nucleic acid detection | |
Yin et al. | Microfluidics-based POCT for SARS-CoV-2 diagnostics | |
Chen et al. | Development of a generic microfluidic device for simultaneous detection of antibodies and nucleic acids in oral fluids | |
Mitsakakis et al. | Diagnostic tools for tackling febrile illness and enhancing patient management | |
Lien et al. | Microfluidic system for detection of α-thalassemia-1 deletion using saliva samples | |
Mumtaz et al. | Prospects of microfluidic technology in nucleic acid detection approaches | |
Hsieh et al. | Bridging the gap between development of point-of-care nucleic acid testing and patient care for sexually transmitted infections | |
Lee et al. | Point-of-care toolkit for multiplex molecular diagnosis of SARS-CoV-2 and influenza A and B viruses | |
Wang et al. | Rapid on-site nucleic acid testing: On-chip sample preparation, amplification, and detection, and their integration into all-in-one systems | |
CA2933515A1 (en) | Amplification of nanoparticle based assay | |
Mauk et al. | Integrated microfluidic nucleic acid isolation, isothermal amplification, and amplicon quantification |